Literature DB >> 28266072

Value-Based Physician Payment in Oncology: Public and Private Insurer Initiatives.

James C Robinson1.   

Abstract

Keywords:  clinical pathways; episode-of-care payment; oncology medical home; value-based payment

Mesh:

Year:  2017        PMID: 28266072      PMCID: PMC5339382          DOI: 10.1111/1468-0009.12249

Source DB:  PubMed          Journal:  Milbank Q        ISSN: 0887-378X            Impact factor:   4.911


× No keyword cloud information.
  14 in total

1.  CMS Takes the Lead In Oncology Payment Reform.

Authors:  Thomas Reinke
Journal:  Manag Care       Date:  2015-10

2.  Comparative effectiveness research and evidence-based health policy: experience from four countries.

Authors:  Kalipso Chalkidou; Sean Tunis; Ruth Lopert; Lise Rochaix; Peter T Sawicki; Mona Nasser; Bertrand Xerri
Journal:  Milbank Q       Date:  2009-06       Impact factor: 4.911

3.  US hospital payment adjustments for innovative technology lag behind those in Germany, France, and Japan.

Authors:  John Hernandez; Susanne F Machacz; James C Robinson
Journal:  Health Aff (Millwood)       Date:  2015-02       Impact factor: 6.301

4.  Medicare innovation center oncology care model: a toe in the water when a plunge is needed.

Authors:  Blase N Polite; Harold D Miller
Journal:  J Oncol Pract       Date:  2015-02-17       Impact factor: 3.840

5.  Changing physician incentives for affordable, quality cancer care: results of an episode payment model.

Authors:  Lee N Newcomer; Bruce Gould; Ray D Page; Sheila A Donelan; Monica Perkins
Journal:  J Oncol Pract       Date:  2014-07-08       Impact factor: 3.840

6.  Centers for medicare and medicaid services: using an episode-based payment model to improve oncology care.

Authors:  Ronald M Kline; Carol Bazell; Erin Smith; Heidi Schumacher; Rahul Rajkumar; Patrick H Conway
Journal:  J Oncol Pract       Date:  2015-02-17       Impact factor: 3.840

7.  Changing physician incentives for cancer care to reward better patient outcomes instead of use of more costly drugs.

Authors:  Lee N Newcomer
Journal:  Health Aff (Millwood)       Date:  2012-04       Impact factor: 6.301

8.  Cost consequences of the 340B drug discount program.

Authors:  Rena M Conti; Peter B Bach
Journal:  JAMA       Date:  2013-05-15       Impact factor: 56.272

Review 9.  Care pathways in US healthcare settings: current successes and limitations, and future challenges.

Authors:  Anita Chawla; Kimberly Westrich; Susanna Matter; Anna Kaltenboeck; Robert Dubois
Journal:  Am J Manag Care       Date:  2016-01       Impact factor: 2.229

10.  Private payers and cancer care: land of opportunity.

Authors:  Ira Klein; Michael Kolodziej
Journal:  J Oncol Pract       Date:  2013-10-01       Impact factor: 3.840

View more
  5 in total

1.  Transformation of the Health Care Industry: Curb Your Enthusiasm?

Authors:  Lawton R Burns; Mark V Pauly
Journal:  Milbank Q       Date:  2018-03       Impact factor: 4.911

2.  What drives variation in spending for breast cancer patients within geographic regions?

Authors:  Anna D Sinaiko; Alyna T Chien; Michael J Hassett; Pragya Kakani; Danielle Rodin; David J Meyers; Belen Fraile; Meredith B Rosenthal; Mary Beth Landrum
Journal:  Health Serv Res       Date:  2018-10-14       Impact factor: 3.402

Review 3.  Impact of Pharmacy Benefit Managers on Oncology Practices and Patients.

Authors:  Trevor J Royce; Caroline Schenkel; Kelsey Kirkwood; Laura Levit; Kathryn Levit; Sheetal Kircher
Journal:  JCO Oncol Pract       Date:  2020-04-20

4.  The economics of alternative payment models for pharmaceuticals.

Authors:  Jakub P Hlávka; Jeffrey C Yu; Dana P Goldman; Darius N Lakdawalla
Journal:  Eur J Health Econ       Date:  2021-03-16

5.  Using claims data to attribute patients with breast, lung, or colorectal cancer to prescribing oncologists.

Authors:  Ezra Fishman; John Barron; Ying Liu; Santosh Gautam; Justin E Bekelman; Amol S Navathe; Michael J Fisch; Ann Nguyen; Gosia Sylwestrzak
Journal:  Pragmat Obs Res       Date:  2019-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.